[1]徐佳莹,于洗河.肾脏替代治疗的应用与效益研究进展[J].卫生经济研究,2023,40(3):24-28，31.
　XU Jiaying,YU Xihe.Research Progress on the Application and Benefit of Kidney Replacement Therapy[J].Journal Press of Health Economics Research,2023,40(3):24-28，31.
点击复制

肾脏替代治疗的应用与效益研究进展

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
40
期数:
2023年3期
页码:
24-28，31
栏目:
经济学评价
出版日期:
2023-03-01

文章信息/Info

Title:
Research Progress on the Application and Benefit of Kidney Replacement Therapy
作者:
徐佳莹1; 于洗河1
1.吉林大学公共卫生学院，吉林 长春 130021
Author(s):
XU Jiaying;  YU Xihe
School of Public Health, Jilin University, Changchun Jilin 130021, China
关键词:
肾脏替代治疗; 肾衰竭; 疾病负担
Keywords:
kidney replacement therapy;  renal failure;  disease burden
分类号:
R19
文献标志码:
A
摘要:
全球慢性肾脏病患者逐年增多，一旦发展至终末期的肾衰竭，会严重影响患者的身心健康，同时造成较大的经济和社会负担。现阶段，肾脏替代治疗（KRT）方法包括血液透析、腹膜透析和肾移植，是降低肾衰竭死亡率、延长患者寿命的有效手段。随着对KRT研究的不断深入，越来越多的证据显示，不同治疗手段的可用性、可及性和可负担性在不同地区呈现明显差异。基于KRT的应用情况，本文分析了KRT效益，主要包括生存年限、副作用、死亡率及危险因素、疾病负担和经济负担，进而提出对策建议。
Abstract:
The number of patients with chronic kidney disease is increasing year by year. The development of end-stage renal failure will seriously affect the physical and mental health of the patients, and cause a large economic and social burden. At present, kidney replacement therapy, including hemodialysis, peritoneal dialysis and kidney transplantation, is an effective means to reduce the mortality rate of renal failure and prolong the life of the patients with renal failure. With the deepening of research on kidney replacement therapy, more and more evidence showed that the availability, accessibility and affordability of different treatments of kidney replacement therapy varied significantly in different regions. At the same time, based on the application of kidney replacement therapy, this paper analyzed the benefits of kidney replacement therapy, including the survival years, side effects, mortality and risk factors, disease burden and economic burden. Finally, through the review and summary of relevant studies, effective suggestions and countermeasures are put forward to provide more powerful evidence for clinical practice.

参考文献/References:

[1] Eknoyan G,Levin,N W.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification[J].Am J Kidney Dis,2002,39(2 Suppl 1):S1-S266.
[2] Stevens P E,Levin A.Evaluation and management of chronic kidney disease:synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline[J].Ann Intern Med,2013,158(11):825-830.
[3] Bauer C,Melamed M L,Hostetter T H.Staging of chronic kidney disease:time for a course correction[J].J Am Soc Nephrol,2008,19(5):844-846.
[4] World Health Organization.World Health Statistics 2020 [R].Geneva: World Health Organization,2020.
[5] Bikbov B,Purcell C,Levey A S,et al.Global,regional,and national burden of chronic kidney disease,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2020,395(10225):709-733.
[6] 白雪莲，张佳宜，项国梁，等.中国成人慢性肾脏病患病率的meta分析[J].中国医药科学，2022，12（9）：49-53.
[7] 前瞻产业研究院.中国血液透析行业发展前景预测与投资战略规划分析报告[R].深圳:前瞻产业研究院，2021.
[8] Fresenius Kabi.Medical care-healthcare professionals[EB/OL]. (2020-01-01)[2022-08-28].https://www.freseniusmedicalcare.cn/.
[9] Liyanage T,Ninomiya T,Jha V,et al.Worldwide access to treatment for end-stage kidney disease:a systematic review[J].Lancet, 2015,385(9981):1975-1982.
[10] Sakhuja V,Sud K.End-stage renal disease in India and Pakistan:burden of disease and management issues[J].Kidney Int Suppl, 2003(83):S115-S118.
[11] Hole B,Hemmelgarn B,Brown E, et al.Supportive care for end-stage kidney disease:an integral part of kidney services across a range of income settings around the world[J].Kidney Int Suppl (2011),2020, 10(1):e86-e94.
[12] 李英.透析基础知识小科普[J].人人健康，2020（1）：40-41.
[13] 曹宁.肾移植前后未透析与透析效果及血液透析与腹膜透析的对比分析[J].中国组织工程研究，2012，16（18）：3357-3364.
[14] Just P M,De Charro F T,Tschosik E A,et al.Reimbursement and economic factors influencing dialysis modality choice around the world[J].Nephrology Dialysis Transplantation,2008,23(7):2365-2373.
[15] Van Eck Van Der Sluijs A,Abrahams A C,Rookmaaker M B,et al.Bleeding risk of haemodialysis and peritoneal dialysis patients[J].Nephrology Dialysis Transplantation,2021,36(1):170-175.
[16] White S L,Chadban S J,Jan S,et al.How can we achieve global equity in provision of renal replacement therapy?[J].Bull World Health Organ,2008,86(3):229-237.
[17] Pecoits-Filho R,Okpechi I G,Donner J A,et al.Capturing and monitoring global differences in untreated and treated end-stage kidney disease,kidney replacement therapy modality,and outcomes[J].Kidney Int Suppl (2011),2020,10(1):e3-e9.
[18] Htay H,Bello A K,Levin A,et al.Hemodialysis use and practice patterns:an international survey study[J].Am J Kidney Dis,2021,77(3):326-335. [19] USRDS.2021 Annual Report. Chronic Kidney Disease:Morbidity and Mortality in Patients with CKD[R].Minneapolis:USRDS,2021.
[20] 国家卫生和计划生育委员会.国家医疗服务与质量安全报告[R].北京:人民卫生出版社，2016.
[21] Zhang L,Zuo L.Current burden of end-stage kidney disease and its future trend in China[J].Clin Nephrol,2016,8627-28.
[22] Keita Y,Ndongo A A,Engome C B,et al.Continuous ambulatory peritoneal dialysis(CAPD) in children:a successful case for a bright future in a developing country[J].Pan Afr Med J,2019,33:71.
[23] Tian X,Guo X,Xia X,et al.The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis[J].Medicine,2019,98(6):e14390.
[24] Saxena R,West C.Peritoneal dialysis:a primary care perspective[J].Journal of the American Board of Family Medicine,2006,19(4):380-389.
[25] Chuasuwan A,Pooripussarakul S,Thakkinstian A,et al.Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis:a systematic review and meta-analysis[J].Health and quality of life outcomes,2020,18(1):1-191.
[26] Bello A K,Levin A,Tonelli M,et al.Assessment of global kidney health care status[J].JAMA,2017,317(18):1864-1881.
[27] Mehrotra R,Soohoo M,Rivara M B,et al.Racial and ethnic disparities in use of and outcomes with home dialysis in the United States[J].J Am Soc Nephrol,2016,27(7):2123-2134.
[28] De Abreu M M,Walker D R, Sesso R C,et al.A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in S?觔o Paulo,Brazil[J].Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis,2013,33(3):304-315.
[29] Gorbatkin C,Bass J,Finkelstein F O,et al.Peritoneal dialysis in austere environments:an emergent approach to renal failure management[J].The Western Journal of Emergency Medicine,2018,19(3):548-556.
[30] 江文诗.全球及我国器官捐献与移植发展特征分析 [EB/OL]. （2019-01-01）[2022-08-28].http://rtzzky.nyfy.com.cn.
[31] Centers For Disease Control.Chronic Kidney Disease.Surveillance System[EB/OL].(2021-09-10)[2022-08-28].https://nccd.cdc.gov/ CKD/.
[32] Zhang L,Guo Y,Ming H. Effects of hemodialysis,peritoneal dialysis,and renal transplantation on the quality of life of patients with end-stage renal disease[Z].Associa?觭?觔o Médica Brasileira,2020:66, 1229-1234.
[33]全国血液透析病例信息登记系统.全国透析现状调研[EB/OL].（2020-01-01）[2022-08-28]. www.CNRDS.NET.
[34] Wang F,Yang C,Long J,et al.Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET)[J].Kidney Int,2019,95(3):501-505.
[35] International Society Of Nephrology. Advancing Kidney Health Worldwide [EB/OL]. (2021-01-01)[2022-08-28].https://www.theisn.org/.
[36] Foroncewicz B,Mucha K,Florczak M,et al.Long-term outcome of renal transplantation:a 10-year follow-up of 765 recipients[J].Pol Arch Intern Med,2019,129(7-8):476-483.
[37] De Jong Y,Van Der Willik E M,Milders J,et al.Person centred care provision and care planning in chronic kidney disease: which outcomes matter?A systematic review and thematic synthesis of qualitative studies[J].BMC Nephrology,2021,22(1):309.
[38] Pretto C R,Winkelmann E R,Hildebrandt L M,et al.Quality of life of chronic kidney patients on hemodialysis and related factors[J].Revista Latino-Americana de Enfermagem,2020,28:3327.
[39] Alencar S B V D,De Lima F M,Dias L D A,et al.Depression and quality of life in older adults on hemodialysis[J].Brazilian Journal of Psychiatry,2020,42(2):195-200.
[40] Murray A M.Cognitive impairment in the aging dialysis and chronic kidney disease populations:an occult burden[J].Adv Chronic Kidney Dis,2008,15(2):123-132.
[41] Grove B E,Schougaard L M,Hjollund N H,et al.Self-rated health,quality of life and appetite as predictors of initiation of dialysis and mortality in patients with chronic kidney disease stages 4-5:a prospective cohort study[J].BMC Research Notes, 2018,11(1):371.
[42] Agarwal R,Georgianos P.Feeding during dialysis-risks and uncertainties[J].Nephrology Dialysis Transplantation,2018,33(6):917-922.
[43] Thamer M,Kaufman J S,Zhang Y,et al.Predicting Early Death Among Elderly Dialysis Patients:Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation[J].Am J Kidney Dis,2015,66(6):1024-1032.
[44] Kim H,Cho M.Factors Influencing Self-Care Behavior and Treatment Adherence in Hemodialysis Patients[J].International Journal of Environmental Research and Public Health,2021,18(24):12934.
[45] Zhang L,Wang F,Wang L,et al.Prevalence of chronic kidney disease in China:a cross-sectional survey[J].Lancet,2012,379(9818):815-822.
[46] Vijayan A.Tackling AKI:prevention, timing of dialysis and follow-up[J].Nat Rev Nephrol,2021,17(2):87-88.
[47] Zhuang Z,Tong M,Clarke R,et al.Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey[J].Clinical Kidney Journal,2022,15(12):2228-2236.
[48] Deng Y,Li N,Wu Y,et al.Global,Regional,and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019[J].Frontiers in Endocrinology,2021,12:672350.
[49] Scott T,Ethier I,Hawley C,et al.Burden of kidney failure from atheroembolic disease and association with survival in people receiving dialysis in Australia and New Zealand:a multi-centre registry study[J].BMC Nephrology,2021,22(1):401.
[50] Nolan C R.Strategies for improving long-term survival in patients with ESRD[J].J Am Soc Nephrol,2005,16 Suppl 2:S120-S127.
[51] Hapca S,Siddiqui M K,Kwan R,et al.The Relationship between AKI and CKD in Patients with Type 2 Diabetes:An Observational Cohort Study[J].J Am Soc Nephrol,2021,32(1):138-150.
[52] Ferguson T W,Whitlock R H,Bamforth R J,et al.Cost-Utility of Dialysis in Canada:Hemodialysis,Peritoneal Dialysis,and Nondialysis Treatment of Kidney Failure[J].Kidney Medicine,2021,3(20):471.
[53] 柯昌荣，赵树勇，玄美燕，等.中国1990—2019年慢性肾病疾病负担及变化趋势分析[J].中国预防医学杂志，2021，22（10）：757-761.
[54] Liu Z H.Nephrology in China[J].Nature Reviews Nephrology,2013,9(9):523-528.
[55] Versino E,Piccoli G.Chronic kidney disease:the complex history of the organization of Long-Term care and bioethics. why now,more than ever,action is needed[J].International Journal of Environmental Research and Public Health,2019,16(5):785.
[56] Centers For Disease Control.General Hospital of Ningxia Medical University Tissue and Organ Bank[EB/OL].(2021-09-10)[2022-08-28].https://nccd.cdc.gov/CKD/.
[57] Zhang H,Zhang C,Zhu S,et al.Direct medical costs of end-stage kidney disease and renal replacement therapy:a cohort study in Guangzhou City,southern China[J].BMC Health Services Research,2020,20(1):122.
[58] De Vries E F,Los J,De Wit G A,et al.Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs[J].BMC Nephrology,2021,22(1):341.
[59] Gorham G,Howard K,Cunningham J,et al.Do remote dialysis services really cost more?An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings[J].BMC Health Services Research,2021,21(1):582.
[60] Small C,Kramer H J,Griffin K A,et al.Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures[J].BMC Nephrology,2017,18(1):3.
[61] Kam-Tao L P,Garcia-Garcia G,Lui S,et al.Kidney health for everyone everywhere - from prevention to detection and equitable access to care[J].Ter Arkh,2020,92(6):4-14.
[62] 高翔，梅长林. 《慢性肾脏病早期筛查、诊断及防治指南（2022年版）》解读[J].中国实用内科杂志，2022，42（9）：735-739.
[63] Curtin R B,Mapes D L.Health care management strategies of long-term dialysis survivors[J].Nephrol Nurs J,2001,28(4):385-392, 393-394.
[64] Lee M C,Wu S V,Hsieh N C,et al.Self-Management Programs on eGFR,Depression,and Quality of Life among Patients with Chronic Kidney Disease:A Meta-Analysis[J].Asian Nurs Res (Korean Soc Nurs Sci),2016,10(4):255-262.
[65] Himmelfarb J,Vanholder R,Mehrotra R,et al.The current and future landscape of dialysis[J].Nature reviews.Nephrology,2020,16(10):573-585.
[66] 赵盼利，濮晓欢，李贝贝.医护一体化护理模式对维持性血液透析患者营养指标及生存质量的影响[J].护理实践与研究， 2021， 18（22）：3390-3393.
[67] Fan H,Zhao Y,Chen G,et al.Health insurance status and risk factors of mortality in patients with septic acute kidney injury in Ningbo,China[J].Journal of International Medical Research,2019,47(1):370-376.

更新日期/Last Update: 2023-03-01